These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15680729)

  • 21. Local activation time derived from stored EGM is associated with failure of antitachycardia pacing in patients with implantable defibrillator.
    Lim HS; Lencioni M; Marshall H
    Pacing Clin Electrophysiol; 2010 May; 33(5):549-52. PubMed ID: 20015127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing cardioverter-defibrillator shock administration by antitachycardia pacing during device charging.
    Arias MA; Puchol A; Castellanos E
    Rev Esp Cardiol; 2008 Oct; 61(10):1087. PubMed ID: 18817684
    [No Abstract]   [Full Text] [Related]  

  • 23. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial.
    Lunati M; Defaye P; Mermi J; Garcia-Alberola A; Merino JL; Arenal A; Cappato R; Navarro X; Passardi M; Santini M
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S35-9. PubMed ID: 17169131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tachycardia pacing for ventricular tachycardia: good even after being bad.
    Arias MA; Puchol A; Castellanos E; Rodríguez-Padial L
    Europace; 2007 Nov; 9(11):1062-3. PubMed ID: 17666444
    [No Abstract]   [Full Text] [Related]  

  • 29. Incessant ventricular tachycardia.
    Germano JJ; Padmanabhan VT; Cohen TJ
    J Invasive Cardiol; 2002 Jun; 14(6):354-7. PubMed ID: 12042632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitachycardia pacing in patients with implantable cardioverter-defibrillators: inverse circadian variation of therapy success and acceleration.
    Fries R; Heisel A; Nikoloudakis N; Jung J; Schäfers HJ; Schieffer H
    Am J Cardiol; 1997 Dec; 80(11):1487-9. PubMed ID: 9399730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ;
    J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: the importance of the patient's sex.
    Peters RW; Zhang X; Gold MR
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):70-4. PubMed ID: 11227973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed termination of ventricular tachycardia after cardioversion.
    Stiles MK; Lau DH; Young GD; Sanders P
    Europace; 2007 Sep; 9(9):730-1. PubMed ID: 17639067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Lemke MJ; Sakaguchi S; Lurie KG; Lu F; Lin J; Benditt DG
    Am J Cardiol; 2005 Jul; 96(2):233-8. PubMed ID: 16018849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology.
    Eur Heart J; 1992 Oct; 13(10):1304-10. PubMed ID: 1396800
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contemporary methods of treatment for ventricular arrhythmias].
    Lelakowski J; Majewski J; Małecka B; Bednarek J; Dreher A
    Pol Merkur Lekarski; 2005 Jul; 19(109):102-7. PubMed ID: 16194040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality, left ventricular ejection fraction, and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with implantable cardioverter defibrillators treated with biventricular pacing versus right ventricular pacing.
    Sukhija R; Aronow WS; Sorbera C; Peterson SJ; Frishman WH; Cohen M
    Am J Ther; 2007; 14(4):328-30. PubMed ID: 17667205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is antitachycardia pacing a safe and efficacious alternative to shocks for fast ventricular tachyarrhythmia treatment?
    Exner DV
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):68-9. PubMed ID: 16265370
    [No Abstract]   [Full Text] [Related]  

  • 40. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients.
    Schaumann A; von zur Mühlen F; Herse B; Gonska BD; Kreuzer H
    Circulation; 1998 Jan 6-13; 97(1):66-74. PubMed ID: 9443433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.